GSA Capital Partners LLP acquired a new position in Catalent Inc (NASDAQ:CTLT) during the second quarter, Holdings Channel reports. The institutional investor acquired 11,740 shares of the company’s stock, valued at approximately $270,000.
A number of other hedge funds also recently added to or reduced their stakes in CTLT. Emerald Acquisition Ltd. acquired a new stake in shares of Catalent during the second quarter valued at about $123,000. LS Investment Advisors LLC increased its stake in shares of Catalent by 85.2% in the second quarter. LS Investment Advisors LLC now owns 7,131 shares of the company’s stock valued at $164,000 after buying an additional 3,280 shares during the period. Strs Ohio increased its stake in shares of Catalent by 17.7% in the second quarter. Strs Ohio now owns 9,300 shares of the company’s stock valued at $213,000 after buying an additional 1,400 shares during the period. Societe Generale acquired a new stake in shares of Catalent during the second quarter valued at about $582,000. Finally, SG Americas Securities LLC increased its stake in shares of Catalent by 3.5% in the second quarter. SG Americas Securities LLC now owns 25,322 shares of the company’s stock valued at $582,000 after buying an additional 862 shares during the period.
Catalent Inc (NASDAQ:CTLT) traded down 2.43% during trading on Thursday, hitting $25.67. 948,436 shares of the stock were exchanged. The stock’s 50-day moving average price is $25.20 and its 200-day moving average price is $25.67. The firm has a market cap of $3.20 billion and a PE ratio of 28.84. Catalent Inc has a 12-month low of $18.92 and a 12-month high of $32.24.
Catalent (NASDAQ:CTLT) last released its earnings results on Monday, August 29th. The company reported $0.52 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.53 by $0.01. The business had revenue of $532.20 million for the quarter. The business’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.61 EPS. On average, equities analysts expect that Catalent Inc will post $1.40 EPS for the current year.
Several analysts have issued reports on the stock. Piper Jaffray Cos. reaffirmed an “overweight” rating and issued a $30.00 price target (down previously from $30.50) on shares of Catalent in a report on Tuesday, August 30th. TheStreet raised shares of Catalent from a “sell” rating to a “hold” rating in a report on Wednesday, August 17th. Jefferies Group reaffirmed a “hold” rating and issued a $25.00 price target on shares of Catalent in a report on Friday, June 10th. Zacks Investment Research raised shares of Catalent from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 5th. Finally, Bank of America Corp. raised shares of Catalent from a “neutral” rating to a “buy” rating and set a $28.00 price target on the stock in a report on Monday, June 20th. They noted that the move was a valuation call. One research analyst has rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $28.67.
In other Catalent news, major shareholder Blackstone Management Associat sold 17,100,705 shares of the firm’s stock in a transaction dated Friday, September 9th. The shares were sold at an average price of $23.58, for a total transaction of $403,234,623.90. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.
Want to see what other hedge funds are holding CTLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Catalent Inc (NASDAQ:CTLT).
Receive News & Ratings for Catalent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc and related companies with MarketBeat.com's FREE daily email newsletter.